Year
2023
-
FDA Approves Pfizer’s Zavzpret in Acute Treatment of Migraine
-
Solanezumab Fails to Halt Amyloid and Cognitive Decline in Preclinical Alzheimer’s
-
US FDA approves Acadia Pharmaceuticals’ Rett syndrome therapy
-
Satellos Bioscience Announces Further Preclinical Progress with SAT-3153 as a Potential Treatment for Duchenne Muscular Dystrophy
-
Ellipses Pharma’s Acute Myeloid Leukemia Candidate Gets Orphan Drug Nod
-
Formology Lab Gets Warning Letter for Lax Identity Testing, Other Lapses
-
Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met
-
FDA Offers Advice on NDAs for Postoperative Local Anesthetics
-
FDA Will Retain Some Guidances After End to COVID Emergency
-
FDA Offers Advice on NDAs for Postoperative Local Anesthetics